Barclays Initiates Coverage On Minimed Group with Equal-Weight Rating, Announces Price Target of $22
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsInitiationPrice Target
Barclays analyst Christopher Pasquale initiates coverage on Minimed Group (NASDAQ:MMED) with a Equal-Weight rating and announces Price Target of $22.
Barclays analyst Christopher Pasquale initiates coverage on Minimed Group (NASDAQ:MMED) with a Equal-Weight rating and announces Price Target of $22.